These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The translation regulatory subunit eIF3f controls the kinase-dependent mTOR signaling required for muscle differentiation and hypertrophy in mouse. Csibi A; Cornille K; Leibovitch MP; Poupon A; Tintignac LA; Sanchez AM; Leibovitch SA PLoS One; 2010 Feb; 5(2):e8994. PubMed ID: 20126553 [TBL] [Abstract][Full Text] [Related]
6. Control of Paip1-eukayrotic translation initiation factor 3 interaction by amino acids through S6 kinase. Martineau Y; Wang X; Alain T; Petroulakis E; Shahbazian D; Fabre B; Bousquet-Dubouch MP; Monsarrat B; Pyronnet S; Sonenberg N Mol Cell Biol; 2014 Mar; 34(6):1046-53. PubMed ID: 24396066 [TBL] [Abstract][Full Text] [Related]
7. The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity. Shahbazian D; Roux PP; Mieulet V; Cohen MS; Raught B; Taunton J; Hershey JW; Blenis J; Pende M; Sonenberg N EMBO J; 2006 Jun; 25(12):2781-91. PubMed ID: 16763566 [TBL] [Abstract][Full Text] [Related]
8. Identification of a conserved motif required for mTOR signaling. Schalm SS; Blenis J Curr Biol; 2002 Apr; 12(8):632-9. PubMed ID: 11967149 [TBL] [Abstract][Full Text] [Related]
9. PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling. Woo SY; Kim DH; Jun CB; Kim YM; Haar EV; Lee SI; Hegg JW; Bandhakavi S; Griffin TJ; Kim DH J Biol Chem; 2007 Aug; 282(35):25604-12. PubMed ID: 17599906 [TBL] [Abstract][Full Text] [Related]
10. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Fingar DC; Salama S; Tsou C; Harlow E; Blenis J Genes Dev; 2002 Jun; 16(12):1472-87. PubMed ID: 12080086 [TBL] [Abstract][Full Text] [Related]
11. mTOR-dependent stimulation of the association of eIF4G and eIF3 by insulin. Harris TE; Chi A; Shabanowitz J; Hunt DF; Rhoads RE; Lawrence JC EMBO J; 2006 Apr; 25(8):1659-68. PubMed ID: 16541103 [TBL] [Abstract][Full Text] [Related]
12. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes. Veilleux A; Houde VP; Bellmann K; Marette A Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102 [TBL] [Abstract][Full Text] [Related]
13. Regulation of translation initiation by amino acids in eukaryotic cells. Kimball SR Prog Mol Subcell Biol; 2001; 26():155-84. PubMed ID: 11575165 [TBL] [Abstract][Full Text] [Related]
14. Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase. Holz MK; Blenis J J Biol Chem; 2005 Jul; 280(28):26089-93. PubMed ID: 15905173 [TBL] [Abstract][Full Text] [Related]
15. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Hara K; Maruki Y; Long X; Yoshino K; Oshiro N; Hidayat S; Tokunaga C; Avruch J; Yonezawa K Cell; 2002 Jul; 110(2):177-89. PubMed ID: 12150926 [TBL] [Abstract][Full Text] [Related]
16. EPRS is a critical mTORC1-S6K1 effector that influences adiposity in mice. Arif A; Terenzi F; Potdar AA; Jia J; Sacks J; China A; Halawani D; Vasu K; Li X; Brown JM; Chen J; Kozma SC; Thomas G; Fox PL Nature; 2017 Feb; 542(7641):357-361. PubMed ID: 28178239 [TBL] [Abstract][Full Text] [Related]
17. eIF3: a connecTOR of S6K1 to the translation preinitiation complex. Peterson TR; Sabatini DM Mol Cell; 2005 Dec; 20(5):655-7. PubMed ID: 16337588 [TBL] [Abstract][Full Text] [Related]
18. Rapamycin inhibits F-actin reorganization and phosphorylation of focal adhesion proteins. Liu L; Chen L; Chung J; Huang S Oncogene; 2008 Aug; 27(37):4998-5010. PubMed ID: 18504440 [TBL] [Abstract][Full Text] [Related]